Hydroxyethyl starch use for patients with postpartum hemorrhage: a review of clinical effectiveness, safety, and guidelines
CADTH
            Record ID 32015000154
            English
                                                            
                Authors' recommendations:
                One clinical practice guideline was identified that recommends the use of isotonic crystalloids over colloids (including hydroxyethyl starch, albumin, modified gelatin, or dextran) for intravenous fluid replacement of women with PPH. This recommendation is based on evidence extrapolated from studies that included critically ill patients, including patients with trauma, burns, sepsis, and surgery. None of the studies included patients with PPH.
            
                                    
            Details
                        
                Project Status:
                Completed
            
                                                            
                Year Published:
                2014
            
                                    
                URL for published report:
                http://www.cadth.ca/media/pdf/htis/oct-2014/RC0587%20Hydroxyethyl%20starch%20Final.pdf
            
                                                            
                English language abstract:
                An English language summary is available
            
                                    
                Publication Type:
                Not Assigned
            
                                    
                Country:
                Canada
            
                                                
                        MeSH Terms
            - Risk Factors
- Postpartum Hemorrhage
- Plasma Substitutes
- Pregnancy
- Female
- Adult
Contact
                        
                Organisation Name:
                Canadian Agency for Drugs and Technologies in Health
            
            
                        
                Contact Address:
                600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
            
                                    
                Contact Name:
                requests@cadth.ca
            
                                    
                Contact Email:
                requests@cadth.ca
            
                                    
                Copyright:
                Canadian Agency for Drugs and Technologies in Health (CADTH)
            
                    
                This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.